Table 1.
Organizations to promote FP, patient access to medical professionals, and current status of FP for adult patients in Asian countries.
Australia | China | Hong Kong | India | Indonesia | Japan | Korea | Philippines | Taiwan | Thailand | Vietnam | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Specialized organization for FP | Yes | Yes | No (in planning) | No | Yes | Yes | Yes | No (in planning) | No | No | No | |
Name of the organization | FUTuRE Fertility | Chinese Maternal and Child Health Association | (Hong Kong Society of Reproductive Medicine) | FPSI (Fertility Preservation Society of India) | Indonesian Association for IVF | JSFP (Japan Society for Fertility Preservation) | KSFP (Korea Society for Fertility Preservation) | PSFP (Philippine Society of Fertility Preservation) | – | – | – | |
Aid fund or insurance for FP | Yes (several) | No | No (in planning) | No | No | No (in planning) | Yes (EC only) | No | No | No | No | |
FP for female | EC | Yes (100–199) | Yes (>200) | Yes (1–49) | Yes (>200) | Yes (1–49) | Yes (100–199) | Yes (1–49) | Yes (6) | Yes (1–49) | Yes (1–49) | Yes (1–49) |
OC | Yes (100–199) | Yes (>200) | Yes (1–49) | Yes (>200) | Yes (1–49) | Yes (100–199) | Yes (1–49) | Yes (6) | Yes (1–49) | Yes (1–49) | Yes (1–49) | |
OTC | Yes (10) | Yes (1–49) | No | Yes (3) | Yes (1–49) | Yes (38) | Yes (1–49) | Yes (1) | Yes (1–49) | Yes (1–49) | No | |
GnRHa | Yes (unknown) | Yes (>200) | Yes (rare) (1–49) | Yes (>200) | Yes (1–49) | Yes (not standard) | Yes (1–49) | Yes (6) | Yes (1–49) | Yes (1–49) | No | |
FP for male | SC | Yes (>200) | Yes (1–49) | Yes (1–49) | Yes (>200) | Yes (1–49) | Yesa (around 100) | Yes (1–49) | Yes (6) | Yes (1–49) | Yes (1–49) | Yes (1–49) |
TTC | Yes (1) | Yes (1–49) | No | Yes (>200) | Yes (1–49) | Yes (rare) | No | No | Yes (1–49) | No | No |
FP, fertility preservation; EC, embryo cryopreservation; OC, oocyte cryopreservation; OTC, ovarian tissue cryopreservation; GnRHa, gonadotropin releasing hormone agonist; SC, sperm cryopreservation; TTC, testicular tissue cryopreservation. aBased on literature (49). Adult patients can be provided EC, OC, and SC as FP in all countries. Compared with OTC, TTC is an uncommon FP treatment. Only Australia and Korea provide funds for FP for patients.